Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Pieris Pharma (PIRS)

Pieris Pharma (PIRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 15,543
  • Shares Outstanding, K 98,935
  • Annual Sales, $ 42,810 K
  • Annual Income, $ -24,540 K
  • 60-Month Beta 0.48
  • Price/Sales 0.38
  • Price/Cash Flow N/A
  • Price/Book 0.63
Trade PIRS with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.29
  • Most Recent Earnings $-0.05 on 03/29/24
  • Latest Earnings Date 05/08/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 0.00% ( unch)
  • Historical Volatility 83.97%
  • IV Percentile 0%
  • IV Rank N/A
  • IV High 0.00% on N/A
  • IV Low 0.00% on N/A
  • Put/Call Vol Ratio N/A
  • Today's Volume N/A
  • Volume Avg (30-Day) N/A
  • Put/Call OI Ratio N/A
  • Today's Open Interest N/A
  • Open Int (30-Day) N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.18
  • Growth Rate Est. (year over year) +555,100.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.1550 +4.84%
on 04/17/24
0.2450 -33.67%
on 03/19/24
-0.0475 (-22.62%)
since 03/18/24
3-Month
0.1485 +9.43%
on 02/14/24
0.2790 -41.76%
on 03/18/24
-0.0040 (-2.40%)
since 01/18/24
52-Week
0.1361 +19.40%
on 12/13/23
1.0100 -83.91%
on 06/13/23
-0.6576 (-80.19%)
since 04/18/23

Most Recent Stories

More News
Pieris Pharmaceuticals: Q3 Earnings Snapshot

Pieris Pharmaceuticals: Q3 Earnings Snapshot

PIRS : 0.1601 (+1.91%)
Pieris Pharmaceuticals (PIRS) Reports Q1 Loss, Lags Revenue Estimates

Pieris Pharmaceuticals (PIRS) delivered earnings and revenue surprises of -28.57% and 70.24%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?...

PIRS : 0.1601 (+1.91%)
MIRO : 3.39 (+0.59%)
Pieris Pharmaceuticals: Q1 Earnings Snapshot

Pieris Pharmaceuticals: Q1 Earnings Snapshot

PIRS : 0.1601 (+1.91%)
AbCellera Biologics Inc. (ABCL) Reports Q1 Loss, Tops Revenue Estimates

AbCellera Biologics Inc. (ABCL) delivered earnings and revenue surprises of -16.67% and 6.76%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?...

ABCL : 3.90 (-0.51%)
PIRS : 0.1601 (+1.91%)
Pieris Pharmaceuticals (PIRS) Reports Q4 Loss, Lags Revenue Estimates

Pieris Pharmaceuticals (PIRS) delivered earnings and revenue surprises of 15.38% and 10.20%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?...

PIRS : 0.1601 (+1.91%)
NEO : 14.08 (+2.92%)
Acadia Healthcare (ACHC) Misses Q4 Earnings Estimates

Acadia Healthcare (ACHC) delivered earnings and revenue surprises of -5.41% and 2.45%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

ACHC : 70.36 (+0.16%)
PIRS : 0.1601 (+1.91%)
Immunocore Holdings PLC Sponsored ADR (IMCR) Surges 6.5%: Is This an Indication of Further Gains?

Immunocore Holdings PLC Sponsored ADR (IMCR) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher...

IMCR : 53.76 (-1.50%)
PIRS : 0.1601 (+1.91%)
Pieris Pharmaceuticals (PIRS) Reports Q3 Loss, Tops Revenue Estimates

Pieris Pharmaceuticals (PIRS) delivered earnings and revenue surprises of 18.75% and 19.04%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?...

PIRS : 0.1601 (+1.91%)
AVEO : 15.00 (unch)
Pieris Pharmaceuticals: Q3 Earnings Snapshot

Pieris Pharmaceuticals: Q3 Earnings Snapshot

PIRS : 0.1601 (+1.91%)
Pieris Pharmaceuticals (PIRS) Reports Q2 Loss, Lags Revenue Estimates

Pieris Pharmaceuticals (PIRS) delivered earnings and revenue surprises of -27.27% and 64.68%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

PIRS : 0.1601 (+1.91%)
IBRX : 5.03 (-4.01%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Pieris Pharmaceuticals, Inc. is a biopharmaceutical company. The Company's drug technology consists of Anticalin(R) to treat cancer, severe asthma, anemia and other medical conditions. Pieris Pharmaceuticals, Inc. is based in Freising-Weihenstephan, Germany.

See More

Key Turning Points

3rd Resistance Point 0.1862
2nd Resistance Point 0.1796
1st Resistance Point 0.1683
Last Price 0.1601
1st Support Level 0.1504
2nd Support Level 0.1438
3rd Support Level 0.1325

See More

52-Week High 1.0100
Fibonacci 61.8% 0.6762
Fibonacci 50% 0.5731
Fibonacci 38.2% 0.4699
Last Price 0.1601
52-Week Low 0.1361

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar